Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal.
Plasmid. 2013 Sep;70(2):247-53. doi: 10.1016/j.plasmid.2013.05.005. Epub 2013 May 22.
A new replicon suitable for cloning and gene expression was successfully introduced into Streptococcus pneumoniae. The non-integrative lactococcal vectors pIL253 (higher-copy) and pIL252 (lower-copy), which are based on the promiscuous theta-replicating plasmid pAMβ1, were established in pneumococcus. The stability and the small size of these plasmids, together with the presence of a helpful multi-cloning site make them a useful genetic tool for gene expression in this bacterium. The functionality of the system was tested by cloning and expressing the pneumococcal RNase R gene in pIL253. Full constitutive expression of the cloned gene was observed, clearly demonstrating that this plasmid can be used as an expression vector in S. pneumoniae. Moreover, gene expression can be regulated by the use of the lower- or higher-copy number vector versions. The existence of other replicative plasmids based on this family, which are also probably functional in pneumococcus, further broadens the cloning possibilities. We also show that S. pneumoniae cells can accommodate simultaneously pIL252 or pIL253 together with pLS1, a pMV158 derivative, which replicates via a rolling circle mechanism. This fact greatly increases the ability to manipulate this bacterium. The availability of a new family of replicative vectors for genetic manipulation in S. pneumoniae is an important contribution to the study of this pathogenic microorganism.
成功将一种适合克隆和基因表达的新复制子引入肺炎链球菌。基于杂合θ复制质粒 pAMβ1 的非整合性乳球菌载体 pIL253(高拷贝数)和 pIL252(低拷贝数)在肺炎链球菌中得以建立。这些质粒的稳定性和小尺寸,以及存在有用的多克隆位点,使它们成为该细菌中基因表达的有用遗传工具。通过在 pIL253 中克隆和表达肺炎球菌 RNase R 基因来测试该系统的功能。观察到克隆基因的完全组成型表达,清楚地表明该质粒可用作 S. pneumoniae 的表达载体。此外,通过使用低拷贝数或高拷贝数载体版本,可以调节基因表达。基于该家族的其他复制质粒的存在,它们在肺炎球菌中可能也具有功能,进一步拓宽了克隆的可能性。我们还表明,肺炎链球菌细胞可以同时容纳 pIL252 或 pIL253 以及 pLS1,pMV158 的衍生物,通过滚环机制复制。这一事实极大地增加了操纵这种细菌的能力。用于肺炎链球菌遗传操作的新型复制载体家族的可用性是对该病原体研究的重要贡献。